SCHEMBL14531237

SCHEMBL14531237

c1ccc(-c2nc(-c3ccc4ccccc4c3)cs2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 1/20 0.69
CDC25B P30305 1/20 0.69
CDC25C P30307 1/20 0.69
DUSP3 P51452 1/20 0.69
KDM4E B2RXH2 6/20 0.67
SMN1; SMN2 Q16637 6/20 0.67
MAPT P10636 4/20 0.67
ALDH1A1 P00352 4/20 0.67
KMT2A Q03164 3/20 0.67
MEN1 O00255 2/20 0.67
LMNA P02545 2/20 0.67
POLB P06746 1/20 0.67
GAA P10253 1/20 0.67
PKM P14618 1/20 0.67
HPGD P15428 1/20 0.67
ALOX12 P18054 1/20 0.67
RAB9A P51151 8/20 0.65
NPC1 O15118 5/20 0.65
AR P10275 3/20 0.65
NFKB1 P19838 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19195913 0.91 CDC25A (0.59) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL26124942 0.89 MAPT (0.68) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL4267715 0.87 KDM4E (0.68) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL11215130 0.85 SREBF2 (0.82) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL11212983 0.85 SREBF2 (0.82) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL11213828 0.85 SREBF2 (0.82) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL4279335 0.85 MAPT (0.74) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL12171396 0.84 CSNK2A1 (0.65) CDC25ACDC25BCDC25CDUSP3KDM4E
SCHEMBL11464717 0.83 SREBF2 (0.79) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A
SCHEMBL2781370 0.83 KDM4E (0.85) KDM4ESMN1; SMN2MAPTALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9656953-B2 Inhibition of cell proliferation UNIVERSITY OF SOUTH FLORIDA (US) 2017-05-23 US disclosed
US-20140221658-A1 INHIBITION OF CELL PROLIFERATION UNIVERSITY OF SOUTH FLORIDA (US) 2014-08-07 US disclosed
US-8642278-B2 Inhibition of cell proliferation UNIVERSITY OF SOUTH FLORIDA (US) 2014-02-04 US disclosed
WO-2007062222-A2 INHIBITION OF CELL PROLIFERATION UNIVERSITY OF SOUTH FLORIDA (US) 2007-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221658-A1 INHIBITION OF CELL PROLIFERATION RB1, RAF1, NRAS CDC25A 103/4885CDC25B 267/4885CDC25C 78/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.